ESC Premium Access

Ranolazine reduces repolarization heterogeneity in symptomatic patients with diabetes, non-obstructive coronary artery disease, and impaired coronary flow reserve

Topic: Diabetes, dysglycaemia and metabolic syndrome

Congress Presentation

About the speaker

Associate Professor Richard Verrier

Beth Israel Deaconess Medical Center, Boston (United States of America)
0 follower

14 more presentations in this session

Obesity paradox and type 2 diabetes mellitus: insights from a prospective follow-up study

Speaker: Doctor A. Antonopoulos (Athens, GR)

Thumbnail

The effect of sodium glucose cotransporter-2 inhibitors, dapagliflozin treatment on epicardial adipose tissue volume

Speaker: Doctor T. Sato (Atami, JP)

Thumbnail

Impact of diabetic status on repeat revascularization following coronary angiography

Speaker: Doctor A. Orbach (Holon, IL)

Thumbnail

impact of diabetes, glycemic control and diabetic retinopathy on mortality and cardiovascular outcomes in a multi-ethnic Asian population.

Speaker: Doctor K. Anbalakan (Singapore, SG)

Thumbnail

Isolated systolic hypertension versus combined systolic-diastolic hypertension as predictors of new-onset diabetes mellitus: Data from a Greek 8-year-follow-up study

Speaker: Doctor K. Dimitriadis (Athens, GR)

Thumbnail

Access the full session

Poster session 5 - Diabetes

Speakers: Associate Professor R. Verrier, Doctor A. Antonopoulos, Doctor T. Sato, Doctor A. Orbach, Doctor K. Anbalakan...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations